Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia.
A. Uranga Echeverria (Galdakaoaldakao, Spain), A. Artaraz (Galdakao, Spain), A. Bilbao (Bilbaoo, Spain), J. Quinatana (Galdakaoo, Spain), I. Arriaga (Bilbao, Spain), M. Intxausti (Bilbaoilbao, Spain), J. Lobo (Vitoira, Spain), J. Garcia (Vitoria, Spain), J. Camino (Barakaldoo, Spain), P. España (Galdakao, Spain)
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Session: Prognosis in bacterial and viral pneumonia
Session type: Thematic Poster
Number: 4546
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Uranga Echeverria (Galdakaoaldakao, Spain), A. Artaraz (Galdakao, Spain), A. Bilbao (Bilbaoo, Spain), J. Quinatana (Galdakaoo, Spain), I. Arriaga (Bilbao, Spain), M. Intxausti (Bilbaoilbao, Spain), J. Lobo (Vitoira, Spain), J. Garcia (Vitoria, Spain), J. Camino (Barakaldoo, Spain), P. España (Galdakao, Spain). Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia.. 4546
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: